Inventor · disambiguated record
Catherine White
Also filed as: WHITE CATHERINE · WHITE CATHERINE M
18 granted patents·4 pending applications·67 citations·filing 2009–2022
91Inventor score
Files withMERCK SHARP & DOHME15MERCK SHARP & DOHME LLC2BRUBAKER JASON1FISCHER CHRISTIAN1GIAMBASU GEORGE MADALIN1
Top patents by PatentIndex Score
22 records- 0192US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 0292US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 0392US9663502B22-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·12 cites·26 claims
- 0492US9657033B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted May 23, 2017·20 cites·44 claims
- 0591US9783511B2Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Oct 10, 2017·9 cites·21 claims
- 0687US10377768B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Aug 13, 2019·6 cites·28 claims
- 0781US10995085B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2020·Granted May 4, 2021·1 cites·12 claims
- 0879US8344144B2Inhibitors of Janus kinasesMERCK SHARP & DOHME·Filed 2009·Granted Jan 1, 2013·5 cites·6 claims
- 0965US10745364B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2019·Granted Aug 18, 2020·0 cites·18 claims
- 1063US10647705B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 12, 2020·0 cites·16 claims
- 1156US12454525B2IL4I1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2021·Granted Oct 28, 2025·0 cites·25 claims
- 1256US2024287022A1Il4i1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 1355US9493441B2Acyclic cyanoethylpyrazoles as janus kinase inhibitorsBRUBAKER JASON·Filed 2012·Granted Nov 15, 2016·0 cites·10 claims
- 1453US2024246937A1Il4i1 inhibitors and methods of useGIAMBASU GEORGE MADALIN·Filed 2022·Application pending·0 cites
- 1549US11103493B2Substituted pyridinyl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Aug 31, 2021·0 cites·18 claims
- 1648US11111232B2Substituted cyclobutylpyridine and cyclobutylpyrimidine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Sep 7, 2021·0 cites·20 claims
- 1746US11319283B2Substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 3, 2022·0 cites·7 claims
- 1845US11319295B2Substituted phenyloxetane and phenyltetrahydrofuran compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 3, 2022·0 cites·15 claims
- 1941US9226922B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 5, 2016·0 cites·15 claims
- 2038US2013116231A1Tyrosine kinase inhibitorsWILSON KEVIN·Filed 2011·Application pending·0 cites
- 2134US10442819B2Tricyclic compounds as inhibitors of mutant IDH enzymesFISCHER CHRISTIAN·Filed 2015·Granted Oct 15, 2019·0 cites·16 claims
- 2231US2012264735A1Tyrosine kinase inhibitorsYOUNG JONATHAN·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Catherine White files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →